Long-term follow-up of high-dose mitoxantrone-based induction therapy for patients with newly-diagnosed acute myelogenous leukemia. Twelve year results from a single institution.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples